vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and Aterian, Inc. (ATER). Click either name above to swap in a different company.
AGIOS PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($20.0M vs $15.1M, roughly 1.3× Aterian, Inc.). Aterian, Inc. runs the higher net margin — -52.5% vs -541.1%, a 488.6% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs -38.5%). Aterian, Inc. produced more free cash flow last quarter ($-1.0M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs -13.5%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Aterian, Inc. is a technology-enabled consumer products company that leverages artificial intelligence and data analytics to identify market demand, develop, source and distribute a wide portfolio of affordable goods spanning home improvement, wellness, personal care, pet supplies and outdoor recreation. It primarily sells its products through leading global e-commerce platforms, with core markets covering North America and Europe.
AGIO vs ATER — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $15.1M |
| Net Profit | $-108.0M | $-7.9M |
| Gross Margin | 90.6% | 56.1% |
| Operating Margin | -608.9% | -51.1% |
| Net Margin | -541.1% | -52.5% |
| Revenue YoY | 86.1% | -38.5% |
| Net Profit YoY | -11.9% | -512.2% |
| EPS (diluted) | $-1.86 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $15.1M | ||
| Q3 25 | $12.9M | $19.0M | ||
| Q2 25 | $12.5M | $19.5M | ||
| Q1 25 | $8.7M | $15.4M | ||
| Q4 24 | $10.7M | $24.6M | ||
| Q3 24 | $9.0M | $26.2M | ||
| Q2 24 | $8.6M | $28.0M | ||
| Q1 24 | $8.2M | $20.2M |
| Q4 25 | $-108.0M | $-7.9M | ||
| Q3 25 | $-103.4M | $-2.3M | ||
| Q2 25 | $-112.0M | $-4.9M | ||
| Q1 25 | $-89.3M | $-3.9M | ||
| Q4 24 | $-96.5M | $-1.3M | ||
| Q3 24 | $947.9M | $-1.8M | ||
| Q2 24 | $-96.1M | $-3.6M | ||
| Q1 24 | $-81.5M | $-5.2M |
| Q4 25 | 90.6% | 56.1% | ||
| Q3 25 | 87.0% | 56.1% | ||
| Q2 25 | 86.3% | 54.3% | ||
| Q1 25 | 87.6% | 61.4% | ||
| Q4 24 | 88.3% | 63.4% | ||
| Q3 24 | 91.3% | 60.3% | ||
| Q2 24 | 82.6% | 60.4% | ||
| Q1 24 | 92.3% | 65.1% |
| Q4 25 | -608.9% | -51.1% | ||
| Q3 25 | -907.4% | -10.7% | ||
| Q2 25 | -1020.1% | -23.1% | ||
| Q1 25 | -1222.0% | -24.1% | ||
| Q4 24 | -1165.3% | -6.5% | ||
| Q3 24 | -1146.9% | -6.6% | ||
| Q2 24 | -1228.3% | -11.5% | ||
| Q1 24 | -1124.3% | -26.1% |
| Q4 25 | -541.1% | -52.5% | ||
| Q3 25 | -803.1% | -12.0% | ||
| Q2 25 | -899.4% | -25.0% | ||
| Q1 25 | -1023.3% | -25.4% | ||
| Q4 24 | -899.6% | -5.3% | ||
| Q3 24 | 10574.7% | -6.8% | ||
| Q2 24 | -1115.7% | -13.0% | ||
| Q1 24 | -995.8% | -25.5% |
| Q4 25 | $-1.86 | — | ||
| Q3 25 | $-1.78 | — | ||
| Q2 25 | $-1.93 | — | ||
| Q1 25 | $-1.55 | — | ||
| Q4 24 | $-1.44 | — | ||
| Q3 24 | $16.22 | — | ||
| Q2 24 | $-1.69 | — | ||
| Q1 24 | $-1.45 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $4.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $15.2M |
| Total Assets | $1.3B | $29.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | $4.9M | ||
| Q3 25 | $92.7M | $7.6M | ||
| Q2 25 | $80.9M | $10.5M | ||
| Q1 25 | $79.0M | $14.3M | ||
| Q4 24 | $76.2M | $18.0M | ||
| Q3 24 | $253.7M | $16.1M | ||
| Q2 24 | $84.5M | $20.3M | ||
| Q1 24 | $118.8M | $17.5M |
| Q4 25 | $1.2B | $15.2M | ||
| Q3 25 | $1.3B | $22.6M | ||
| Q2 25 | $1.4B | $24.3M | ||
| Q1 25 | $1.5B | $27.0M | ||
| Q4 24 | $1.5B | $30.0M | ||
| Q3 24 | $1.6B | $30.6M | ||
| Q2 24 | $660.5M | $30.9M | ||
| Q1 24 | $743.9M | $33.0M |
| Q4 25 | $1.3B | $29.6M | ||
| Q3 25 | $1.4B | $40.1M | ||
| Q2 25 | $1.5B | $45.4M | ||
| Q1 25 | $1.6B | $49.8M | ||
| Q4 24 | $1.7B | $49.5M | ||
| Q3 24 | $1.8B | $52.1M | ||
| Q2 24 | $773.1M | $59.9M | ||
| Q1 24 | $849.7M | $55.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $-1.0M |
| Free Cash FlowOCF − Capex | $-97.3M | $-1.0M |
| FCF MarginFCF / Revenue | -487.5% | -6.9% |
| Capex IntensityCapex / Revenue | 5.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $-1.0M | ||
| Q3 25 | $-88.2M | $-1.6M | ||
| Q2 25 | $-77.1M | $-4.4M | ||
| Q1 25 | $-111.5M | $-3.9M | ||
| Q4 24 | $-133.2M | $-9.0K | ||
| Q3 24 | $-84.2M | $-722.0K | ||
| Q2 24 | $-72.6M | $2.9M | ||
| Q1 24 | $-99.9M | $-6.0K |
| Q4 25 | $-97.3M | $-1.0M | ||
| Q3 25 | $-89.7M | $-1.6M | ||
| Q2 25 | $-78.0M | $-4.4M | ||
| Q1 25 | $-112.3M | — | ||
| Q4 24 | $-134.1M | — | ||
| Q3 24 | $-84.6M | — | ||
| Q2 24 | $-72.7M | $2.9M | ||
| Q1 24 | $-100.0M | $-42.0K |
| Q4 25 | -487.5% | -6.9% | ||
| Q3 25 | -696.5% | -8.4% | ||
| Q2 25 | -626.2% | -22.7% | ||
| Q1 25 | -1286.4% | — | ||
| Q4 24 | -1250.1% | — | ||
| Q3 24 | -944.2% | — | ||
| Q2 24 | -844.4% | 10.3% | ||
| Q1 24 | -1221.2% | -0.2% |
| Q4 25 | 5.6% | 0.0% | ||
| Q3 25 | 12.1% | 0.2% | ||
| Q2 25 | 7.0% | 0.0% | ||
| Q1 25 | 8.8% | 0.0% | ||
| Q4 24 | 9.0% | 0.0% | ||
| Q3 24 | 4.7% | 0.0% | ||
| Q2 24 | 1.8% | 0.0% | ||
| Q1 24 | 1.7% | 0.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGIO
Segment breakdown not available.
ATER
| Sales Channel Directly To Consumer | $13.1M | 87% |
| Heating Cooling And Air Quality | $2.1M | 14% |
